Chronic inflammation caused by senescent T cells can compromise proteostasis and lead to mitochondrial dysfunction, contributing to immunosenescence
New GLP-1 Bridge Program for Medicare Patients The new Medicare GLP-1 Bridge program allows eligible Medicare beneficiaries to access certain GLP-1 weight-loss medications for as little as $50 per month
The drugs you hear about, Ozempic and Wegovy (both semaglutide) and Mounjaro (tirzepatide, which also targets GIP), are synthetic versions of GLP-1 that are much more potent and stay in the body much longer
Most treatments require 8-12 weeks of consistent use before showing results
In this blog, we delve into the anti-aging superpowers of GHK-Cu and explain how this scientifically tested peptide helps rejuvenate aging skin
Metaflammation (inflammation of metabolism) Inflammation linked to insulin resistance, obesity, or chronic stress